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Zonisamide is a novel anticonvulsant that prevents seizures in laboratory animals and in man. Zonisamide (3 &ml and above) 
blocked the sustained firing of action potentials induced by depolarizing steps of current injected across the membrane of intracellular- 
ly recorded spinal cord neurons. Responses to GABA and glutamate were not altered by zonisamide, and spontaneous synaptically 
evoked activity was not reduced until higher concentrations of zonisamide (lO,@ml) were applied. 
INTRODUCTION 
Zonisamide (AD 810, CI 912) (1,2-benzisoxa- 
zole-3-methanesulfonamide, Fig. 1) is a novel an- 
ticonvulsant compound that has recently been 
tested in controlled clinical trials1’,13. Clinical stud- 
ies demonstrate significant therapeutic effects 
against partial seizures. The clinical and animal 
pharmacological profile of zonisamide is very simi- 
lar to that of phenytoin or carbamazepine”. 
Phenytoin, carbamazepine, and valproate are 
effective therapy against generalized tonic-clonic 
seizures and block sustained repetitive firing of so- 
dium action potentials in vitro at doses that do not 
affect postsynaptic inhibitory or excitatory neuro- 
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transmitter responses3s5-7. The blockade of repeti- 
tive firing appears to be a use-dependent block of 
Na+ channels, shifting these channels into a more 
inactivated state3,4”4”5. Phenytoin and carbama- 
zepine displace the specific binding of batracho- 
toxinin to sodium channels of mammalian neu- 
rons16 and may have their effects on sodium action 
potentials by acting at this molecular site. Such ac- 
tions may be important correlates of the anticon- 
vulsant activity of these compounds1,3. The cur- 
rent electrophysiological experiments were per- 
formed to see if zonisamide affects sodium-depen- 
dent action potentials of mammalian neurons at 
relevant concentrations. Preliminary results have 
been presented previously’. 
Clinical therapeutic whole plasma levels of zonis- 
amide are 15-20 pug/ml and nearly all patients 
show marked neurological side effects at whole 
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plasma levels above 40 ,q/ml (H. Bockbrader, 
personal communication). Since at these concen- 
trations zonisamide is 50% bound to plasma pro- 
teins”, we estimate that the free fraction of plasma 
zonisamide or the cerebrospinal fluid concentra- 
tion of zonisamide is 7.5-12.5 ,@ml (estimated 
therapeutic range) and that levels at and above 20 
&ml (unbound to plasma proteins) are thought to 
cause neurological side effects. 
MATERIALS AND METHODS 
Cell culture 
Cultures of spinal cord neurons were prepared 
by standard methods’. Briefly, spinal cords and 
dorsal root ganglia were dissected from fetal 
(12-14 days gestation) mouse embryos. The tissue 
was minced, mechanically dissociated and plated 
in sterile collagen-coated 35 mm dishes. Growth 
media consisted of: 80% Eagle’s minimal essential 
media supplemented with 5.5 g glucose and 1.5 g 
NaHCO,/l, 10% heat-inactivated horse serum and 
10% fetal calf serum adjusted to 325 mosM. The 
cultures were maintained in an incubator with an 
atmosphere of 90% room air and 10% CO, at 
35 “C. The NaCO,/CO, buffer maintained pH at 
7.4. Growth of rapidly dividing non-neuronal cells 
was suppressed by treatment with uridine and 5- 
fluoro-Zdeoxyuridine after 6-8 days in vitro. Me- 
dium was changed twice weekly thereafter and did 
not contain fetal calf serum. Cultures were main- 
tained at least 4 weeks before electrophysiological 
experiments. 
Experimental procedures 
Cultures were placed on the heated stage of an 
inverted phase contrast microscope where intra- 
cellular impalements were obtained with high re- 
sistance glass micropipettes (20-60 MQ) filled 
with either 4 M KAc or 3 M KCl. Membrane po- 
tential was recorded with a high-impedance bridge 
amplifier (Dagan 8100) and recorded on analog 
magnetic tape. The experimental medium was 
Dulbecco’s phosphate-buffered saline (DPBS; 
NaCl 137 mM, KC1 3 mM, Na*HPO, 8 mM, 
KH,PO, 1.5 mM, MgCl, 1 mM (spontaneous ac- 
tivity experiments) or 10 mM MgCl, (repetitive 
firing and iontophoretic experiments) ,CaCl, 1 
mM, glucose 10 mM, pH 7.3-7.4). Zonisamide 
was dissolved into dimethyl sulfoxide (DMSO) 
with a final concentration of DMSO not greater 
than 0.1% in drug solutions applied to neurons. 
The experiments were run at temperatures be- 
tween35and37 “C. 
Tests were performed to determine the effect of 
zonisamide on (a) sustained repetitive firing of so- 
dium action potentials, (b) spontaneous neuronal 
activity, and (c) iontophoretic GABA and gluta- 
mate responses. 
Repetitive firing 
Only cultures in which all cells exhibited sus- 
tained repetitive firing (3-5 neurons examined per 
culture) in control medium were used for experi- 
ments. To elicit repetitive firing, 450 msec depo- 
larizing current pulses of varying amplitudes were 
used. If a neuron fired action potentials through- 
out any of the 450 msec pulses, firing was judged 
as sustained. In order to be included, resting mem- 
brane potential of a neuron had to be greater than 
-40 mV with overshooting action potentials. After 
addition of zonisamide to the bath, additional neu- 
rons were tested at membrane potentials of ap- 
proximately -50 mV for the ability to fire sus- 
tained action potentials. Data are expressed as the 
percentage of cells showing sustained firing. The 
IC,, value for the blockade of repetitive firing was 
determined by probit analysis2. 
Spontaneous activity 
Impaled cells were rated for the amount of 
(spontaneous) synaptically evoked action poten- 
tials (Fig. 4A). Neurons were judged on the fol- 
lowing scale: grade 2 - normal activity - pres- 
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tentials (EPSPs and IPSPs) measured indirectly by 
the frequency of action potentials; grade 1 - re- 
duced activity - greatly decreased frequency of 
action potentials indicating fewer EPSPs; grade 0 
- quiescence - no spontaneous action potentials 
or synaptic potentials. Resting membrane poten- 
tial of all cells was greater than -40 mV. Only cul- 
tures exhibiting grade 2 spontaneous activity in 
control medium (3-5 cells examined per cuhure) 
were used. Significant reductions in spontaneous 
activity were determined by comparison of the 
scores from drug-treated neurons with those be- 
fore drug addition using the Wilcoxon rank-sum 
test. 
Iontophoretic experiments 
GABA (0.5 M, pH 3.2, positive current) or glu- 
tamate (0.4 M, pH 10, negative current) was 
ejected by passing 400 msec current pulses every 5 
set from a high resistance micropipette placed ap- 
proximately 2 pm from the impaled cell. Retaining 
current (negative for GABA and positive for glu- 
tamate) was applied to prevent leakage between 
pulses. Membrane potential was hyperpolarized 
from -60 to -80 mV by passing current through 
the recording micropipette. Since recording mi- 
cropipettes in GABA experiments were KC&filled, 
E,,- was shifted to approximately -30 mV due to 
leakage of Cl- into the cells. Thus, GABA applica- 
tion resulted in depolarizing responses. Recording 
micropipettes in glutamate experiments were 
filled with potassium acetate. Iontophoretic cur- 
rent was adjusted so that responses were approxi- 
mately 10 mV in amplitude. Zonisamide was ap- 
plied by pressure ejection (0.25-1.0 pounds/in.‘, 
30 set) from blunt tipped (~10 pm) micropipettes 
placed 30-100 ,um from the cell. Data were ex- 
pressed as percentage of control amplitude and 
were discarded if the response failed to return to 
control levels after drug application. 
RESULTS 
Effect of zonisamide on sustained repetitive firing 
In control medium, neurons responded to 450 
1.2 nA 
I-L 
Control R?,W=-55 mV Zonisamide RMP=-60 mV 
3 ug/ml 
Fig. 2. Effect of zonisamide (3 ygiml) on sustained repetitive firing. In control media (left panel) increasing depolarizing current steps 
(nA current intensities at the right of each trace) increased number and frequency of action potentials. A different cell bathed in 3 
@ml zonisamide (right panel) no longer fired action potentials throughout the depolarizing step. Resting membrane potential (RMP) 
is indicated at the bottom of each panel. Calibration: vertical bar 50 mV, horizontal bar 200 msec. 
0.1 0.3 1.0 3.0 10.0 30.0 
Concentrlltion (&ml) 
Fig. 3. Concentration dependence of zonisamide on sustained 
repetitive firing (SBF). The percentage of cell exhibiting sus- 
tained repetitive firing is plotted as a function of concentration 
of zonisamide. The estimated therapeutic range (7.5-12.5 
pgiml) is indicated by the black bar. Numbers in parentheses 
represent number of cells tested at each concentration. 
msec depolarizing current steps with trains of ac- 
tion potentials; increasing the magnitude of depo- 
larization resulted in increased number and fre- 
quency of action potentials (Fig. 2, left panel). Ap- 
plication of 3 pug/ml zonisamide (Fig. 2, right 
panel) blocked the ability of cells to respond with 
sustained firing throughout the depolarizing cur- 
rent pulse. Zonisamide blocked sustained repeti- 
(A) (8) 
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tive firing in a concentration-dependent manner 
(Fig. 3) and the concentration that blocked sus- 
tained repetitive firing in 50% of the cells (IC,,) 
was 3.7 pg/ml (1.8-7.5,95% confidence interval). 
Effect of zonisamide on spontaneous activity 
Spinal cord cells in culture make functional syn- 
aptic connections, and therefore intracellular re- 
cordings from neurons in control medium exhibit 
spontaneous excitatory and inhibitory postsynap- 
tic potentials (EPSPs and IPSPs) and action poten- 
tials. Cells were graded according to the frequency 
of occurrence of action potentials (an indirect 
measure of the frequency of synaptic potentials, 
see Fig. 4A). Zonisamide reduced spontaneous 
synaptic activity in a concentration-dependent 
manner with significant reductions from control at 
10 and 30pglml (Fig. 4B). 
Effect of zonisamide on iontophoretic GABA and 
glutamate responses 
High concentrations of zonisamide (30 pg/ml) 
had no significant effect on GABA responses 
(drug-treated GABA responses were a mean of 
98% * 3.5% S.E.M. of control, N = 6) or gluta- 
mate responses (103% ? 3.2% of control, N = 5) 
- 
Grade 0 
I ‘-..‘-..-.. ‘. I/ I= :.: q Crmde , : . . ‘. :., Grads 0 
Fig. 4. Effect of zonisamide on spontaneous neuronal activity. A: rating scale for the measurement of spontaneous activity (see Meth- 
ods). Grade 2, normal spontaneous activity; grade 1, reduced spontaneous activity; grade 0, quiescence, no spontaneous activity. 
Tracings are intracellular recordings from cells of each grade, resting membrane potentials were all greater than -40 mV. B: concen- 
tration-dependent reduction of spontaneous activity by zonisamide. Bars summarize data from 8 or more cells and are divided to rep- 
resent the percentage of cells with each grade at a given concentration of zonisamide. Spontaneous activity was significantly reduced 
at both 10 and 30 &ml. 
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Fig. 5. Zonisamide (3Opgiml) had no effect on either GABA or 
glutamate (GLU) responses. Tracings were from cells that 
were hyperpolarized to around -80 mV by injection of current. 
Calibration: vertical bar 5 mV, horizontal bar 1 sec. 
(Fig. 5). No change in membrane voltage or con- 
ductance was observed when zonisamide was ap- 
plied to neurons from micropipettes at this concen- 
tration. 
DISCUSSION 
These experiments demonstrate that zonisamide 
selectively blocks sustained repetitive action po- 
tentials in mammalian neurons at concentrations 
that are expected to be present in the extracellular 
fluid of the brain during anticonvulsant treatment. 
Blockade of repetitive firing is dose related, with 
an IC,, of approximately 2 @ml. It is likely that 
zonisamide blocks repetitive firing by changing so- 
dium current inactivation kinetics (similar to phe- 
nytoin and carbam~epine) since only the later ac- 
tion potentials of a train are blocked (Fig. 3). 
These findings are compatible with the observa- 
tions of Schauf” who found that zonisamide also 
selectively alters the inactivation of voltage-sensi- 
tive sodium currents in voltage-clamped annelid 
worm axons in vitro. Steady-state fast inactivation 
in these axons occurs at more hyperpolarized 
membrane potentials in the presence of zonis- 
amide. Such changes are similar to those reported 
in cultured spinal cord neurons3 or in voltage- 
clamped neuroblastoma cells4,‘4,‘5 for phenytoin 
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